Relationship Between Polypharmacy and Frailty in Older Adults: Which Frailty Assessment Tool Shows the Relationship Best?

Main Article Content

Guzin CAKMAK
Zeynel Abidin Öztürk

Keywords

frailty, polypharmacy, potentially inappropriate medicine use, TIME, Fried, SOF

Abstract

Frailty syndrome is one of the geriatric syndromes that carries an increased risk for adverse health outcomes. This study aims to investigate the relationship between frailty and polypharmacy in the elderly. This cross-sectional study was conducted for a period of 4 months from September 2019 to January 2020. Frailty was assessed by using the Fried Frailty Index (FFI) and SOF (Study of Osteoporotic Fractures) Index. Patients were evaluated for inappropriate medication use by TIME (Turkish Inappropriate Medication Use in the Elderly) criteria. Data analysis was done by using SPSS version 22. The study population was composed of 93 women and 57 men, and the mean age was 73 +/- 9 years. The frequency of polypharmacy was %73 (n=110). Presence of polypharmacy and number of drugs used were related to both FFI and SOF index scores. We found that the FFI score was associated with number of drugs used in regression analysis (r²=0.166, p<0.001). The relationship between multimorbidity and frailty was also demonstrated by FFI(p=0.01). We showed a cut-off value of 6.5 of drug numbers for being frail according to the FFI index in the ROC curve (sensitivity:68%; specificity:62%; p<0.001; CI:95%; AUC:0.693). The frequency of inappropriate medicine use was 38%. In this study, we revealed that frailty was related to polypharmacy. We also found that FFI reveals the relationship between polypharmacy and frailty more precisely than the SOF index. Prospective studies to evaluate the effect of decreasing the number of used drugs on frailty could be useful.

Downloads

Download data is not yet available.
Abstract 2 | PDF Downloads 3

References

1. United Nations. Department of Economic and Social Affairs, Population Division (2017). World population ageing 2017 - Highlights. 2017. 46 p.
2. Introduction I. World Health Day 2012 - Ageing and Health " Good health adds life to years " Toolkit for event organizers. World Health. 2012;1–20.
3. Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet [Internet]. 2019;394(10206):1365–75. Available from: http://dx.doi.org/10.1016/S0140-6736(19)31786-6
4. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in Older Adults: Evidence for a Phenotype. Journals Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M146–57.
5. Boxberger et al. 2008. 基因的改变NIH Public Access. Bone. 2008;23(1):1–7.
6. Little MO. Updates in nutrition and polypharmacy. Curr Opin Clin Nutr Metab Care. 2018;21(1):4–9.
7. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet [Internet]. 2012;380(9836):37–43. Available from: http://dx.doi.org/10.1016/S0140-6736(12)60240-2
8. Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int oral Heal JIOH [Internet]. 2014;6(6):i–ii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25628499%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4295469
9. Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol. 2017;73(9):1165–72.
10. Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R, et al. Frailty and multimorbidity: A systematic review and meta-analysis. Journals Gerontol - Ser A Biol Sci Med Sci. 2019;74(5):659–66.
11. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;
12. Shelkey M, Wallace M. Katz Index of Independence in Activities of Daily Living (ADL). Director. 2000;
13. Oort Q, Taphoorn MJB, Sikkes SAM, Uitdehaag BMJ, Reijneveld JC, Dirven L. Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors. J Neurooncol [Internet]. 2019;143(1):1–13. Available from: http://dx.doi.org/10.1007/s11060-019-03136-9
14. Chu LW, Chiu AYY, Chi I. Impact of falls on the balance, gait, and activities of daily living functioning in community-dwelling Chinese older adults. Journals Gerontol - Ser A Biol Sci Med Sci. 2006;61(4):399–404.
15. Barry E, Galvin R, Keogh C, Horgan F, Fahey T. Is the Timed Up and Go test a useful predictor of risk of falls in community dwelling older adults: A systematic review and meta- analysis. BMC Geriatr. 2014;14(1).
16. Lin X, Haralambous B, Pachana NA, Bryant C, Logiudice D, Goh A, et al. Screening for depression and anxiety among older Chinese immigrants living in Western countries: The use of the Geriatric Depression Scale (GDS) and the Geriatric Anxiety Inventory (GAI). Asia-Pacific Psychiatry. 2016;8(1):32–43.
17. Cao L, Chen S, Zou C, Ding X, Gao L, Liao Z, et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Heal Aging. 2014;18(3):277–83.
18. Gąsior JS, Pawłowski M, Williams CA, Dąbrowski MJ, Rameckers EA. Assessment of maximal isometric hand grip strength in school-aged children. Open Med. 2018;13(1):22–8.
19. Bahat G, Tufan A, Kilic C, Aydın T, Akpinar TS, Kose M, et al. Cut-off points for height, weight and body mass index adjusted bioimpedance analysis measurements of muscle mass with use of different threshold definitions. Aging Male [Internet]. 2018;0(0):1–6. Available from: https://doi.org/10.1080/13685538.2018.1499081
20. Bohannon RW, Wang YC. Four-Meter Gait Speed: Normative Values and Reliability Determined for Adults Participating in the NIH Toolbox Study. Arch Phys Med Rehabil [Internet]. 2019;100(3):509–13. Available from: https://doi.org/10.1016/j.apmr.2018.06.031
21. Bahat G, Ilhan B, Erdogan T, Halil M, Savas S, Ulger Z, et al. Turkish inappropriate medication use in the elderly ( TIME ) criteria to improve prescribing in older adults : TIME ‑ to ‑ STOP / TIME ‑ to ‑ START . Eur Geriatr Med [Internet]. 2020;(0123456789). Available from: https://doi.org/10.1007/s41999-020-00297-z
22. Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero, Inzitari M, Martínez-Velilla N. The relationship between frailty and polypharmacy in older people: A systematic review. Br J Clin Pharmacol. 2018;84(7):1432–44.
23. Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A, et al. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study. J Am Med Dir Assoc [Internet]. 2017;18(7):624–8. Available from: http://dx.doi.org/10.1016/j.jamda.2017.02.009
24. Sutorius FL, Hoogendijk EO, Prins BAH, Van Hout HPJ. Comparison of 10 single and stepped methods to identify frail older persons in primary care: Diagnostic and prognostic accuracy. BMC Fam Pract [Internet]. 2016;17(1):1–12. Available from: http://dx.doi.org/10.1186/s12875-016-0487-y
25. Esses G, Andreopoulos E, Lin HM, Arya S, Deiner S. A Comparison of Three Frailty Indices in Predicting Morbidity and Mortality after On-Pump Aortic Valve Replacement. Anesth Analg. 2018;126(1):39–45.
26. Hirai K, Tanaka A, Homma T, Kaneko K, Uno T, Sato H, et al. Comparison of three frailty models and a sarcopenia model in elderly patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int. 2019;19(9):896–901.
27. Henry L, Halpin L, Barnett SD, Pritchard G, Sarin E, Speir AM. Frailty in the Cardiac Surgical Patient: Comparison of Frailty Tools and Associated Outcomes. Ann Thorac Surg [Internet]. 2019;108(1):16–22. Available from: https://doi.org/10.1016/j.athoracsur.2019.03.009
28. Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: A Cochrane systematic review. BMJ Open. 2015;5(12).
29. Kojima T, Mizukami K, Tomita N, Arai H, Ohrui T, Eto M, et al. Screening Tool for Older Persons’ Appropriate Prescriptions in Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly.” Geriatr Gerontol Int. 2016;16(9):983–1001.
30. Zia A, Kamaruzzaman SB, Tan MP. Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk. Postgrad Med. 2015;127(3):330–7.
31. Bahat G, Ilhan B, Erdogan T, Halil M, Savas S, Ulger Z, et al. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. Eur Geriatr Med [Internet]. 2020;11(3):491–8. Available from: https://doi.org/10.1007/s41999-020-00297-z
32. Leszek S, Jadwiga JO, Agnieszka BS. Polypharmacy as a risk factor for depressive symptoms in geriatric patients: An observational, cross-sectional study. Ars Pharm. 2016;57(3):127–35.
33. Carlson R V., Boyd KM, Webb DJ. The revision of the Declaration of Helsinki: Past, present and future. Br J Clin Pharmacol. 2004;57(6):695–713.